Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Short term Debt: 2022-2023

Historic Short term Debt for Gossamer Bio (GOSS) over the last 2 years, with Dec 2023 value amounting to $11.6 million.

  • Gossamer Bio's Short term Debt fell 17.43% to $9.6 million in Q1 2024 from the same period last year, while for Mar 2024 it was $9.6 million, marking a year-over-year decrease of 17.43%. This contributed to the annual value of $11.6 million for FY2023, which is negligibly% changed negligibly from last year.
  • As of FY2023, Gossamer Bio's Short term Debt stood at $11.6 million, which was down 0.00% from $11.6 million recorded in FY2022.
  • Gossamer Bio's 5-year Short term Debt high stood at $11.6 million for FY2022, and its period low was $11.6 million during FY2022.
  • Moreover, its 2-year median value for Short term Debt was $11.6 million (2023), whereas its average is $11.6 million.